Physician profile
Meera Patel
NPI 1619052529
$111,787.97
in general payments reported to CMS, 2019-2025
11 companies · $4,197 in 2025
The $4,197 reported for 2025 was more than what 94% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $20K · 2021: $15K · 2022: $14K · 2023: $16K · 2024: $26K · 2025: $4,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Travel and Lodging: $1,839 · Consulting Fee: $1,142 · Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,600.00 |
| Travel and Lodging | $1,839.06 |
| Consulting Fee | $1,142.00 |
| Food and Beverage | $879.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $104,470.34 | 2019-2025 | Imfinzi |
| Bayer Healthcare Pharmaceuticals INC. | $3,997.00 | 2020-2023 | |
| Novocure INC. | $2,408.66 | 2019-2025 | Optune, Optune Lua (Novottf-200t) |
| Ethicon INC. | $413.23 | 2021-2025 | Monarch Platform |
| Visionrt, INC. | $207.47 | 2019 | |
| Veran Medical Technologies, INC. | $164.53 | 2020 | |
| Genmab U.S., INC. | $34.41 | 2023 | Tivdak |
| Brainlab, INC. | $31.99 | 2023 | Image Guided Surgical Device |
| Daiichi Sankyo INC. | $24.16 | 2022 | |
| Blue Earth Diagnostics | $23.00 | 2023 | |
| Eisai INC. | $13.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meera Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.